LIVECAST Markets Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics News Archive Account

Home News ArchiveDuality Biotherapeutics’ Phase 3 DYNASTY-BREAST02 Trial Meets Primary Endpoint

Live News EQUITY FLASH M impact Oct 26, 2026, 11:16 AM UTC

Duality Biotherapeutics’ Phase 3 DYNASTY-BREAST02 Trial Meets Primary Endpoint

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

Moderna shares fall 6.4% Moderna shares fell 6.4% after Citi maintained its bearish rating following the release of complete melanoma vaccine data. M impact | EQUITY | Oct 26, 2026, 03:06 PM UTC RBC Expects Mondelez Q3 Revenue In Line, EPS Slightly Below Consensus RBC Capital Markets expects Mondelez to report third-quarter revenue in line with expectations and EPS slightly below consensus. M impact | EQUITY | Oct 26, 2026, 03:06 PM UTC Teledyne FLIR Defense Secures USD48 Million Contract Teledyne FLIR Defense secured a contract for Bulgaria's Stryker fleet. M impact | EQUITY | Oct 26, 2026, 03:05 PM UTC Court Orders Liquidation Phase for Tubos Reunidos Tubos Reunidos says a court has ordered the opening of its liquidation phase. M impact | EQUITY | Oct 26, 2026, 03:05 PM UTC Nvidia, Micron Lead Listed Stocks Higher, With Gains Up to 3.5% Nvidia rose 3.1%, Microsoft 1.1%, Amazon 1%, Broadcom 2.8%, Micron Technology 3.5% and SpaceX 1.4%. M impact | EQUITY | Oct 26, 2026, 03:05 PM UTC Morton Salt Ceases Operations at Fairport Mine Morton Salt announced it has ceased operations at the Fairport mine. M impact | EQUITY | Oct 26, 2026, 03:03 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Macro
Politics
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.